pharma
New cancer clinical trial model promises to cut costs and development time
May 15, 2018Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, Cancer, MD AndersonCancer Center, clinical trials, pharma
Researchers from the University of Texas MD Anderson Cancer Center have been developing and testing a new model for the …
FDA issues warning letter over potential for poisoning at India plant
May 15, 2018Manufacturing and Production FDA, India, biotech, drugs, pharma, pharmaceutical
The FDA has noted a number of failings at a plant in Gujarat, India, but mostly significantly was the finding …
Smell test targets asymptomatic malaria carriers
May 15, 2018Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical
Asymptomatic carriers of malaria may be responsible for the onwards transmission of up to 90% of cases, highlighting the importance …
Emergex secures funds in race to develop universal flu vaccine
May 15, 2018Manufacturing and Production, Sales and Marketing Emergex, Innovate UK, biotech, drugs, influenza vaccine, pharma, pharmaceutical
UK-based biotech, Emergex Vaccines, has received £1 million to push its universal flu vaccine through preclinical tests, in the hope …
Lilly chalks up another acquisition with AurKa for $575m
May 14, 2018Manufacturing and Production, Sales and Marketing AurKa, Cancer, Eli Lilly, acquisition, oncology, pharma
Swiftly following up its $1.6 billion splash to pick up Armo BioSciences last week, Eli Lilly has agreed to acquire …
Bringing the PRO to fruition
May 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PROs, feature, patient reported outcomes, patient-reported outcomes, pharma
Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …
Medigene and bluebird bio expand immunotherapy partnership to $1.5bn
May 14, 2018Research and Development, Sales and Marketing Bluebird Bio, Cancer, Medigene, pharma
Medigene has announced that it has bolstered the existing partnership it has in place with US firm bluebird bio, originally …
Takeda financials show why the Shire deal was needed
May 14, 2018Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …
Pharma unfazed by Trump price-reduction proposals
May 14, 2018Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical
President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …
FDA awards first paediatric MS approval to Novartis’ Gilenya
May 14, 2018Sales and Marketing FDA, gilenya, multiple sclerosis, pharma
The FDA has awarded approval for what it says is its first drug for the treatment of multiple sclerosis (MS) …
Janssen’s Tremfya gets go-ahead from NICE in plaque psoriasis
May 11, 2018Medical Communications, Sales and Marketing Janssen, NICE, Tremfya, UK, pharma, psoriasis
NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the …
Top Ten most popular articles on Pharmafile.com this week
May 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical
It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …
Roche’s Tecentriq/Cotellic combo therapy fails to impress in colorectal cancer
May 11, 2018Medical Communications, Research and Development Cancer, Cotellic, Roche, pharma, tecentriq
Roche has been rocked by a Phase 3 weak showing from its combination Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people …
AZ’s Fasenra stumbles in P3 for COPD
May 11, 2018Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical
AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …
C4 Therapeutics fills out C-Suite with CEO appointment
May 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical
C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
